Pharmala Biotech Holdings Inc. (CSE:MDMA)

Market Cap	22.24M
Revenue	n/a
Net Income	n/a
Shares Out	103.45M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	53,224
Average Volume	191,972
Open	0.210
Previous Close	0.215
Day's Range	0.205 - 0.230
52-Week Range	0.065 - 0.340
Beta	1.21
RSI	37.55
Earnings Date	n/a

About Pharmala Biotech Holdings

Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredient under the LaNeo brand name. The company is headquartered in Vancouver, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Nicholas Kadysh
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: MDMA